BRCA2 and ovarian carcinoma: Interestingly, PLC13 carried the pathogenic mutation c.3860delA in BRCA2 (confirmed as a germline mutation) and had a family record in which her mother had an ovary carcinoma and her daughter debuted with breast carcinoma at the age of 30.